Short communication · 30 Dec 2025
Conference abstractPublished 14 Sep 2015
Clofazimine biocrystals and immunomodulation
University of Michigan, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Clofazimine (CFZ) is a clinically useful antibiotic on the WHO’s list of essential medicines for the treatment of leprosy. Since it’s initial use in 1969, CFZ has cured over 16 million leprosy patients with no reports of drug resistance. Therefore, with the global emergence of drug-resistant microbials, CFZ has received renewed interest. In mice, as in humans, orally administered CFZ is actively sequestered as a mechanism of drug detoxification by tissue resident macrophages, where it is mostly found as intracellular crystal-like drug inclusions (CLDIs). Although there have been several reports of CFZ immunomodulatory action, the underlying mechanism for this property is mainly unknown. With the purpose of elucidating immunomodulatory mechanisms, our studies have shown that CLDI’s possess functions that include the downregulation of Toll-like receptor expression and pro-inflammatory pathways, while upregulating anti-inflammatory pathways in macrophages without exhibiting toxicity. Furthermore, with the use of well-established animal injury models (lung and foot) we have shown that CLDI’s are associated with increased IL-1RA production, leading to profound systemic anti-inflammatory activity. In light of new knowledge on the safety and activity of CLDIs, we are currently researching into the reformulation and repurposing of CFZ as synthetic CLDIs for the treatment of inflammatory disorders such as COPD and rheumatoid arthritis.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Drug Metabolism & Toxicology.
Opinion · 30 Dec 2025
Hepatic metabolism forms the foundation of drug disposition in the human body
Opinion · 30 Dec 2025
Biomarkers of Toxicity for Monitoring Adverse Drug Reactions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Drug Metabolism & Toxicology
- SubjectDiabetes & Endocrinology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Gi Sang Yoon”
- BylineArticles whose byline prints “Rahul K Keswani”
- BylineArticles whose byline prints “Sudha Sud”
- BylineArticles whose byline prints “Theodore J Standiford”
- BylineArticles whose byline prints “Kathleen A Stringer”
- BylineArticles whose byline prints “Gus R Rosania”

